Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
Novo Nordisk A/S
Chantal Mathieu; Björg Ásbjörnsdóttir; Harpreet S Bajaj; Wendy Lane; Ana Laura S A Matos; Sreenivasa Murthy; Karolina Stachlewska; Julio Rosenstock